✦ LIBER ✦

Time course of response to nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis

✍ Scribed by Daniel J. Lovell; Edward H. Giannini; Earl J. Brewer Jr

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 306 KB
Volume: 27
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780271216

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The rise and decline of nonsteroidal ant

The rise and decline of nonsteroidal antiinflammatory drug–associated gastropathy in rheumatoid arthritis

✍ James F. Fries; Kirsten N. Murtagh; Mihoko Bennett; Ernesto Zatarain; Bharathi L 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Abstract ## Objective Nonsteroidal antiinflammatory drug (NSAID)–associated gastropathy is a major cause of hospitalization and death. This study was undertaken to examine whether recent preventive approaches have been associated with a declining incidence of NSAID gastropathy, and, if so, what

Genetic predictors of patient response a

Genetic predictors of patient response and side effects in the treatment of rheumatoid arthritis with a high dose nonsteroidal antiinflammatory drug regimen

✍ Elliott Semble; Douglas Metcalf; Robert Turner; Carlos Agudelo; Edward Pisko; A. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views

## Abstract Clinical, laboratory, genetic, and radiologic studies were evaluated for 18 patients with rheumatoid arthritis who were treated for a mean of 16.6 months with a regimen involving supplementary aspirin and piroxicam, an investigational, nonsteroidal antiinflammatory agent. Although impro

Nonsteroidal antiinflammatory drug thera

Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis patients. Lack of association between clinical improvement and effects on sleep

✍ P. Lavie; M. Nahir; M. Lorber; Y. Scharf 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB 👁 2 views

Thirteen patients with rheumatoid arthritis (mean & SD age 55.8 f 10.5 years) received 20 mg of tenoxicam daily for 90 days following a 3-7-day "washout" period and 4 days of placebo treatment. Clinical evaluations were conducted at the end of the washout period and at monthly intervals thereafter.

Cardiovascular outcomes in new users of

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: High-risk subgroups and time course of risk

✍ Daniel H. Solomon; Jerry Avorn; Til Stürmer; Robert J. Glynn; Helen Mogun; Sebas 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Cost-effectiveness of biologics in polya

Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs

✍ Wendy J. Ungar; Vania Costa; Rebecca Hancock-Howard; Brian M. Feldman; Ronald M. 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 150 KB 👁 2 views

## Abstract ## Objective Juvenile idiopathic arthritis (JIA) is the most common chronic pediatric rheumatic disease and can have long‐term effects leading to disability in adulthood. Biologics are a new class of drugs increasingly used to treat JIA. The primary study objective was to determine the

Disease activity early in the course of

Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients

✍ Daniel Aletaha; Julia Funovits; Edward C. Keystone; Josef S. Smolen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views